Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Current Leases: 2021-2025

Historic Current Leases for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $2.7 million.

  • Kiniksa Pharmaceuticals International's Current Leases rose 32.74% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 32.74%. This contributed to the annual value of $2.0 million for FY2024, which is 11.54% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Current Leases stood at $2.7 million, which was up 6.90% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Current Leases peaked at $3.5 million during Q1 2023, and registered a low of $2.0 million during Q4 2024.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Current Leases had a median value of $2.3 million in 2024 and averaged $2.4 million.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 39.47% in 2022, then plummeted by 34.55% in 2024.
  • Kiniksa Pharmaceuticals International's Current Leases (Quarterly) stood at $3.4 million in 2021, then fell by 2.37% to $3.3 million in 2022, then plummeted by 31.75% to $2.3 million in 2023, then declined by 11.54% to $2.0 million in 2024, then skyrocketed by 32.74% to $2.7 million in 2025.
  • Its Current Leases was $2.7 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.3 million in Q1 2025.